383 related articles for article (PubMed ID: 2502914)
1. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
[TBL] [Abstract][Full Text] [Related]
2. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
Campbell PJ; Rickard KA
Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion therapy in haemophilia.
Varon D; Martinowitz U
Haemophilia; 1998 Jul; 4(4):431-5. PubMed ID: 9873771
[TBL] [Abstract][Full Text] [Related]
4. Results of secondary prophylaxis in children with severe hemophilia.
Manco-Johnson MJ; Nuss R; Geraghty S; Funk S; Kilcoyne R
Am J Hematol; 1994 Oct; 47(2):113-7. PubMed ID: 8092125
[TBL] [Abstract][Full Text] [Related]
5. The safety of pharmacologic options for the treatment of persons with hemophilia.
Franchini M; Mannucci PM
Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
[TBL] [Abstract][Full Text] [Related]
6. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
7. How do we optimally utilize factor concentrates in persons with hemophilia?
Lim MY
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):206-214. PubMed ID: 34889393
[TBL] [Abstract][Full Text] [Related]
8. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
Berntorp E
Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
[TBL] [Abstract][Full Text] [Related]
9. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
[TBL] [Abstract][Full Text] [Related]
10. Factor concentrate usage in persons with hemophilia in New York State.
Linden JV; Kolakoski MH; Lima JE; Du P; Lipton RA
Transfusion; 2003 Apr; 43(4):470-5. PubMed ID: 12662279
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion of monoclonal antibody-purified factor VIII.
Weinstein RE; Bona RD; Rickles FR
Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates.
Roth DA; Kessler CM; Pasi KJ; Rup B; Courter SG; Tubridy KL;
Blood; 2001 Dec; 98(13):3600-6. PubMed ID: 11739163
[TBL] [Abstract][Full Text] [Related]
13. Hemostasis: a practical review of conservative and operative care.
Shopnick RI; Brettler DB
Clin Orthop Relat Res; 1996 Jul; (328):34-8. PubMed ID: 8653974
[TBL] [Abstract][Full Text] [Related]
14. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.
Martinowitz U; Schulman S; Gitel S; Horozowski H; Heim M; Varon D
Br J Haematol; 1992 Dec; 82(4):729-34. PubMed ID: 1482660
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with continuous infusion of coagulation factor concentrates in severe hemophilia A complicated with mixed trauma, crush syndrome and acute renal failure].
Griniūte R; Gerbutavicius R; Pilvinis V; Pamerneckas A
Medicina (Kaunas); 2005; 41(10):857-60. PubMed ID: 16272833
[TBL] [Abstract][Full Text] [Related]
17. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
18. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis in haemophilic children.
Liesner RJ
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
